Yatin Suneja
Stock Analyst at Guggenheim
(4.86)
# 373
Out of 5,040 analysts
434
Total ratings
48.8%
Success rate
23.4%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $80 | $34.63 | +131.01% | 1 | Oct 5, 2026 | |
| MPLT MapLight Therapeutics | Initiated Coverage: Hold | n/a | $9.15 | - | 1 | Oct 5, 2026 | |
| NBIX Neurocrine Biosciences | Initiated Coverage: Buy | $222 → $207 | $141.25 | +46.55% | 15 | Oct 5, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $20 | $4.13 | +384.26% | 8 | Oct 2, 2026 | |
| KRSA Korsana Biosciences | Initiated Coverage: Buy | $70 | $33.51 | +108.89% | 1 | Sep 28, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $100 | $29.30 | +241.30% | 11 | Sep 22, 2026 | |
| TRAX First Tracks Biotherapeutics | Initiated Coverage: Buy | $100 | $32.01 | +212.40% | 1 | Sep 16, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | n/a | $4.90 | - | 10 | Sep 15, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $42 → $46 | $34.21 | +34.46% | 11 | Sep 8, 2026 | |
| ALMS Alumis | Downgraded: Hold | n/a | $6.97 | - | 7 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $14.79 | +238.07% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $79.90 | +62.70% | 7 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $1.95 | +720.51% | 10 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $26.24 | +109.60% | 4 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $7.56 | +825.93% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $275 | $170.08 | +61.69% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $77.28 | +158.80% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $10.86 | +222.28% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $13.43 | +257.41% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $8.62 | +422.04% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $800 | $263.55 | +203.55% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $36.16 | +148.89% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $82.43 | +142.63% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1,135 → $1,185 | $818.63 | +44.75% | 26 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,000 → $1,030 | $739.57 | +39.27% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $22 | $7.13 | +208.56% | 17 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 → $280 | $218.43 | +28.19% | 28 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $9.55 | +434.03% | 7 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $89.05 | +96.52% | 10 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $3.46 | +1,865.32% | 9 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $62 | $30.26 | +104.89% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.90 | +417.24% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.53 | +815.03% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.4798 | +2,817.88% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $23.95 | +150.52% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 → $100 | $5.74 | +1,642.16% | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $46.21 | +202.96% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.58 | +89.04% | 11 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $2.70 | n/a | 11 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $19.58 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $45 | $27.97 | n/a | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.09 | n/a | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.17 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $17.15 | n/a | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.00 | n/a | 2 | May 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $123 | $31.92 | n/a | 7 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $1.22 | n/a | 1 | Jul 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $32 | $14.12 | n/a | 4 | Dec 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $53.34 | n/a | 6 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.12 | n/a | 1 | Aug 13, 2014 |
LB Pharmaceuticals
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $34.63
Upside: +131.01%
MapLight Therapeutics
Oct 5, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $9.15
Upside: -
Neurocrine Biosciences
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $222 → $207
Current: $141.25
Upside: +46.55%
Zura Bio
Oct 2, 2026
Reiterated: Buy
Price Target: $20
Current: $4.13
Upside: +384.26%
Korsana Biosciences
Sep 28, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $33.51
Upside: +108.89%
Celldex Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $100
Current: $29.30
Upside: +241.30%
First Tracks Biotherapeutics
Sep 16, 2026
Initiated Coverage: Buy
Price Target: $100
Current: $32.01
Upside: +212.40%
Sionna Therapeutics
Sep 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.90
Upside: -
Roivant Sciences
Sep 8, 2026
Reiterated: Buy
Price Target: $42 → $46
Current: $34.21
Upside: +34.46%
Alumis
Sep 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.97
Upside: -
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $14.79
Upside: +238.07%
Aug 26, 2026
Reiterated: Buy
Price Target: $130
Current: $79.90
Upside: +62.70%
Aug 13, 2026
Reiterated: Buy
Price Target: $16
Current: $1.95
Upside: +720.51%
Aug 13, 2026
Reiterated: Buy
Price Target: $55
Current: $26.24
Upside: +109.60%
Aug 11, 2026
Reiterated: Buy
Price Target: $70
Current: $7.56
Upside: +825.93%
Aug 10, 2026
Reiterated: Buy
Price Target: $260 → $275
Current: $170.08
Upside: +61.69%
Aug 10, 2026
Reiterated: Buy
Price Target: $200
Current: $77.28
Upside: +158.80%
Aug 7, 2026
Reiterated: Buy
Price Target: $35
Current: $10.86
Upside: +222.28%
Aug 6, 2026
Reiterated: Buy
Price Target: $50 → $48
Current: $13.43
Upside: +257.41%
Aug 6, 2026
Reiterated: Buy
Price Target: $45
Current: $8.62
Upside: +422.04%
Aug 6, 2026
Reiterated: Buy
Price Target: $800
Current: $263.55
Upside: +203.55%
Aug 6, 2026
Reiterated: Buy
Price Target: $90
Current: $36.16
Upside: +148.89%
Aug 5, 2026
Reiterated: Buy
Price Target: $200
Current: $82.43
Upside: +142.63%
Aug 4, 2026
Initiated Coverage: Buy
Price Target: $1,135 → $1,185
Current: $818.63
Upside: +44.75%
Aug 3, 2026
Reiterated: Buy
Price Target: $1,000 → $1,030
Current: $739.57
Upside: +39.27%
Jul 31, 2026
Reiterated: Buy
Price Target: $25 → $22
Current: $7.13
Upside: +208.56%
Jul 21, 2026
Rated: Buy
Price Target: $260 → $280
Current: $218.43
Upside: +28.19%
Jul 17, 2026
Reiterated: Buy
Price Target: $51
Current: $9.55
Upside: +434.03%
Jul 1, 2026
Reiterated: Buy
Price Target: $175
Current: $89.05
Upside: +96.52%
Jun 24, 2026
Reiterated: Buy
Price Target: $68
Current: $3.46
Upside: +1,865.32%
May 26, 2026
Reiterated: Buy
Price Target: $44 → $62
Current: $30.26
Upside: +104.89%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $2.90
Upside: +417.24%
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $1.53
Upside: +815.03%
May 7, 2026
Reiterated: Buy
Price Target: $14
Current: $0.4798
Upside: +2,817.88%
May 7, 2026
Reiterated: Buy
Price Target: $60
Current: $23.95
Upside: +150.52%
Mar 13, 2026
Reiterated: Buy
Price Target: $128 → $100
Current: $5.74
Upside: +1,642.16%
Mar 4, 2026
Reiterated: Buy
Price Target: $140
Current: $46.21
Upside: +202.96%
Feb 24, 2026
Reiterated: Buy
Price Target: $20
Current: $10.58
Upside: +89.04%
Sep 29, 2025
Reiterated: Buy
Price Target: $26
Current: $2.70
Upside: n/a
Feb 27, 2025
Reiterated: Hold
Price Target: $20
Current: $19.58
Upside: n/a
Jan 3, 2025
Upgraded: Buy
Price Target: $45
Current: $27.97
Upside: n/a
Dec 11, 2024
Downgraded: Hold
Price Target: n/a
Current: $8.09
Upside: n/a
Sep 21, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $3.17
Upside: n/a
May 31, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $17.15
Upside: n/a
May 15, 2020
Reiterated: Buy
Price Target: $9
Current: $1.00
Upside: n/a
Jul 20, 2018
Reiterated: Buy
Price Target: $115 → $123
Current: $31.92
Upside: n/a
Jul 13, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $1.22
Upside: n/a
Dec 12, 2017
Reiterated: Buy
Price Target: $21 → $32
Current: $14.12
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: n/a
Current: $53.34
Upside: n/a
Aug 13, 2014
Reiterated: Buy
Price Target: n/a
Current: $19.12
Upside: n/a